Abstract
Provided herein are novel P2X3 inhibitors, pharmaceutical compositions, use of such compounds in treating neurogenic disorders, such as gynecological disorders, urinary tract disorders, respiratory disorders, and pain-associated disorders, and processes for preparing such compounds.